TNGX
Tango Therapeutics, Inc.
+0.71 (+3.04%)24.06USD597K成交股數4.1B市值–本益比(近四季)75.4股價營收比-100.0%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00-100% | 0.00-100% | 53.8M+364% | 3.2M-84% | 5.4M-17% | 4.1M-62% | 11.6M-20% | 19.9M+245% | 6.5M | 10.7M | 14.6M | 5.8M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 37.2M | 33.5M | 30.8M | 32.8M | 36.4M | 33.9M | 33.3M | 38.7M | 38.1M | 27.1M | 28.7M | 28.0M |
| 銷售管理費用 | 22.6M | 15.2M | 8.9M | 11.3M | 11.5M | 11.1M | 11.2M | 10.8M | 10.7M | 9.2M | 9.2M | 8.0M |
| 營業利益 | −59.8M+41% | −48.8M+19% | 14.1M-143% | −41.0M+39% | −42.5M+1% | −40.9M+60% | −32.9M+41% | −29.6M-2% | −42.3M | −25.6M | −23.2M | −30.3M |
| 營業利益率 | – | – | 26.2% | -1,287.9% | -788.8% | -993.9% | -283.3% | -148.7% | -653.0% | -238.8% | -159.2% | -525.3% |
| 稅後淨利 | −55.3M+39% | −45.5M+21% | 15.9M-154% | −38.9M+52% | −39.9M+5% | −37.7M+69% | −29.2M+41% | −25.6M-9% | −37.9M | −22.3M | −20.7M | −28.0M |
| 淨利率 | – | – | 29.5% | -1,221.4% | -739.5% | -915.2% | -251.3% | -128.6% | -585.9% | -207.4% | -141.9% | -485.7% |
| 稀釋 EPS | -0.37+3% | -0.32-3% | 0.13-148% | -0.35+46% | -0.36+3% | -0.33+43% | -0.27+17% | -0.24-25% | -0.35 | -0.23 | -0.23 | -0.32 |
| 稀釋股數 | 150M | 144M | 118M | 111M | 110M | 109M | 109M | 108M | 108M | 97.0M | 88.4M | 88.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 346M | 158M | 58.3M | 39.3M | 58.4M | 69.5M | 53.1M | 51.6M | 61.2M | 58.5M | 66.1M | 57.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.1B | 436M | 210M | 238M | 274M | 316M | 352M | 381M | 406M | 428M | 379M | 404M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 49.3M | 44.3M | 50.1M | 103M | 108M | 117M | 123M | 134M | 142M | 152M | 166M | 177M |
| 股東權益 | 1.0B | 392M | 160M | 135M | 167M | 200M | 229M | 248M | 264M | 277M | 213M | 227M |
| 負債比 | 4.6% | 10.2% | 23.8% | 43.3% | 39.2% | 37.0% | 35.0% | 35.1% | 34.9% | 35.4% | 43.9% | 43.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −44.4M | – | – | −41.7M+10% | – | – | – | −37.9M | – | – | −34.9M |
| 資本支出 | – | −2K | – | – | 51K | – | – | – | 195K | – | – | 620K |
| 自由現金流 | – | −44.4M | – | – | −41.7M+10% | – | – | – | −38.1M | – | – | −35.5M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | -774.3% | – | – | – | -588.0% | – | – | -616.1% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 62.4M
| Collaboration Revenue | 62.4M | 100.0% | +108.2% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 62.4M | +48.3% | −102M | -162.9% | -0.87 | −140M |
| FY2024 | 42.1M | +15.2% | −130M | -309.7% | -1.19 | −132M |
| FY2023 | 36.5M | +46.9% | −102M | -278.4% | -1.08 | −120M |
| FY2022 | 24.9M | -32.9% | −108M | -435.1% | -1.23 | −117M |
| FY2021 | 37.0M | +383.8% | −58.2M | -157.2% | -0.94 | −61.4M |
| FY2020 | 7.7M | – | −52.0M | -678.8% | -1.63 | 69.0M |